Clinical Trial Update: Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor atorvastatin to prevent severe acute graft-versus-host disease in patients undergoing myeloablative peripheral blood stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Malignant Neoplasm

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Malignant Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2017-08-17